{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:32:56Z","timestamp":1792708376048,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00432-014-1744-x","type":"journal-article","created":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T09:11:17Z","timestamp":1404205877000},"page":"1883-1890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO"],"prefix":"10.1007","volume":"140","author":[{"given":"Anle","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujun","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanminh","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"key":"1744_CR1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.183.3.725","volume":"183","author":"T Boon","year":"1996","unstructured":"Boon T, van der Bruggen P (1996) Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725\u2013729","journal-title":"J Exp Med"},{"key":"1744_CR2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2005.08.047","volume":"116","author":"TA Chatila","year":"2005","unstructured":"Chatila TA (2005) Role of regulatory T cells in human diseases. J Allergy Clin Immunol 116:949\u2013959 quiz 60","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1744_CR3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cyto.2011.12.013","volume":"58","author":"YH Chen","year":"2012","unstructured":"Chen YH, Kuo ML, Cheng PJ, Hsaio HS, Lee PT, Lin SJ (2012) Regulation of CD28 expression on umbilical cord blood and adult peripheral blood CD8+ T cells by interleukin(IL)-15\/IL-21. Cytokine 58(1):40\u201346","journal-title":"Cytokine"},{"issue":"4","key":"1744_CR4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.intimp.2012.09.006","volume":"14","author":"X Du","year":"2012","unstructured":"Du X, Zhao B, Li J, Cao X, Diao M, Feng H, Chen X, Chen Z, Zeng X (2012) Astragalus polysaccharides enhance immune responses of HBV DNA vaccination via promoting the dendritic cell maturation and suppressing Treg frequency in mice. Int Immunopharmacol 14(4):463\u2013470","journal-title":"Int Immunopharmacol"},{"key":"1744_CR5","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1084\/jem.20042167","volume":"201","author":"AM Ercolini","year":"2005","unstructured":"Ercolini AM et al (2005) Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response. J Exp Med 201:1591\u20131602","journal-title":"J Exp Med"},{"key":"1744_CR6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","volume":"9","author":"F Fallarino","year":"2002","unstructured":"Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A et al (2002) T cell apoptosis by tryptophan catabolism. Cell Death Diff 9:1069\u20131077","journal-title":"Cell Death Diff"},{"key":"1744_CR7","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","volume":"176","author":"F Fallarino","year":"2006","unstructured":"Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C et al (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176:6752\u20136761","journal-title":"J Immunol"},{"key":"1744_CR8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ijc.10645","volume":"101","author":"M Friberg","year":"2002","unstructured":"Friberg M, Jennings R, Alsarraj M, Dessureault S, Cantor A, Extermann M et al (2002) Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int J Cancer 101:151\u2013155","journal-title":"Int J Cancer"},{"issue":"1\u20132","key":"1744_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.molimm.2011.08.017","volume":"49","author":"J Godin-Ethier","year":"2011","unstructured":"Godin-Ethier J, Hanafi LA, Duvignaud JB, Leclerc D, Lapointe R (2011) IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive. Mol Immunol 49(1\u20132):253\u2013259","journal-title":"Mol Immunol"},{"issue":"8","key":"1744_CR10","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.fitote.2012.08.019","volume":"83","author":"LF Huang","year":"2012","unstructured":"Huang LF, Yao YM, Li JF, Zhang SW, Li WX, Dong N, Yu Y, Sheng ZY (2012) The effect of Astragaloside IV on immune function of regulatory T cell mediated by high mobility group box 1 protein in vitro. Fitoterapia 83(8):1514\u20131522","journal-title":"Fitoterapia"},{"issue":"3","key":"1744_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.cr.7290282","volume":"15","author":"SL Hwang","year":"2005","unstructured":"Hwang SL, Chung NP, Chan JK, Lin CL (2005) Indoleamine 2,3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines. Cell Res 15(3):167\u2013175","journal-title":"Cell Res"},{"key":"1744_CR12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2013.02.027","volume":"60","author":"X Li","year":"2013","unstructured":"Li X, Wang X, Han C, Wang X, Xing G, Zhou L, Li G, Niu Y (2013a) Astragaloside IV suppresses collagen production of activated HSCs via oxidative stress-mediated p38 MAPK pathway. Free Radic Biol Med 60:168\u2013176","journal-title":"Free Radic Biol Med"},{"key":"1744_CR13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.freeradbiomed.2013.02.027","volume":"60","author":"X Li","year":"2013","unstructured":"Li X, Wang X, Han C, Wang X, Xing G, Zhou L, Li G, Niu Y (2013b) Astragaloside IV suppresses collagen production of activated HSCs via oxidative stress-mediated p38 MAPK pathway. Free Radic Biol Med 60:168\u2013176","journal-title":"Free Radic Biol Med"},{"key":"1744_CR14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrc1929","volume":"6","author":"AJ Muller","year":"2006","unstructured":"Muller AJ, Scherle PA (2006) Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. Nat Rev Cancer 6:613\u2013625","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1744_CR15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.coi.2006.01.002","volume":"18","author":"DH Munn","year":"2006","unstructured":"Munn DH (2006) Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Curr Opin Immunol 18(2):220\u2013225","journal-title":"Curr Opin Immunol"},{"key":"1744_CR16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","volume":"117","author":"DH Munn","year":"2007","unstructured":"Munn DH, Mellor AL (2007) Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117:1147\u20131154","journal-title":"J Clin Invest"},{"issue":"1","key":"1744_CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1189\/jlb.0209086","volume":"87","author":"H Nguyen","year":"2010","unstructured":"Nguyen H, Weng NP (2010) IL-21 preferentially enhances IL-15-mediated homeostatic proliferation of human CD28+ CD8 memory T cells throughout the adult age span. J Leukoc Biol 87(1):43\u201349","journal-title":"J Leukoc Biol"},{"key":"1744_CR18","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1073\/pnas.0503852102","volume":"102","author":"H Nishikawa","year":"2005","unstructured":"Nishikawa H et al (2005) Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. Proc Natl Acad Sci USA 102:9253\u20139257","journal-title":"Proc Natl Acad Sci USA"},{"issue":"28","key":"1744_CR19","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1038\/onc.2008.35","volume":"27","author":"GC Prendergast","year":"2008","unstructured":"Prendergast GC (2008) Immune escape as a fundamental trait of cancer: focus on IDO. Oncogene 27(28):3889\u20133900","journal-title":"Oncogene"},{"key":"1744_CR20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","volume":"1","author":"TW Stone","year":"2002","unstructured":"Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609\u2013620","journal-title":"Nat Rev Drug Discov"},{"key":"1744_CR21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1756-9966-30-82","volume":"30","author":"J Sun","year":"2011","unstructured":"Sun J, Yu J, Li H, Yang L, Wei F, Yu W, Liu J, Ren X (2011) Upregulated expression of indoleamine 2,3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells. J Exp Clin Cancer Res 30:82","journal-title":"J Exp Clin Cancer Res"},{"key":"1744_CR22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.194.6.823","volume":"194","author":"RP Sutmuller","year":"2001","unstructured":"Sutmuller RP et al (2001) Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 194:823\u2013832","journal-title":"J Exp Med"},{"key":"1744_CR23","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","volume":"9","author":"C Uyttenhove","year":"2003","unstructured":"Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N et al (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269\u20131274","journal-title":"Nat Med"},{"issue":"1","key":"1744_CR24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2013.07.038","volume":"340","author":"X Wu","year":"2013","unstructured":"Wu X, Peng M, Huang B, Zhang H, Wang H, Huang B, Xue Z, Zhang L, Da Y, Yang D, Yao Z, Zhang R (2013) Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarcoma. Cancer Lett 340(1):124\u2013133","journal-title":"Cancer Lett"},{"key":"1744_CR25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ni1059","volume":"5","author":"Y Yang","year":"2004","unstructured":"Yang Y, Huang CT, Huang X, Pardoll DM (2004) Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol 5:508\u2013515","journal-title":"Nat Immunol"},{"issue":"2","key":"1744_CR26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ygyno.2010.01.019","volume":"117","author":"R Yigit","year":"2010","unstructured":"Yigit R, Massuger LF, Figdor CG, Torensma R (2010) Ovarian cancer creates a suppressive microenvironment to escape immune elimination. Gynecol Oncol 117(2):366\u2013372","journal-title":"Gynecol Oncol"},{"issue":"22","key":"1744_CR27","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1158\/1078-0432.CCR-08-0991","volume":"14","author":"N Yoshida","year":"2008","unstructured":"Yoshida N, Ino K, Ishida Y, Kajiyama H, Yamamoto E, Shibata K, Terauchi M, Nawa A, Akimoto H, Takikawa O, Isobe K, Kikkawa F (2008) Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model. Clin Cancer Res 14(22):7251\u20137259","journal-title":"Clin Cancer Res"},{"key":"1744_CR28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.20041684","volume":"201","author":"P Yu","year":"2005","unstructured":"Yu P et al (2005) Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 201:779\u2013791","journal-title":"J Exp Med"},{"issue":"8","key":"1744_CR29","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.4049\/jimmunol.177.8.5639","volume":"177","author":"X Zheng","year":"2006","unstructured":"Zheng X, Koropatnick J, Li M, Zhang X, Ling F, Ren X, Hao X, Sun H, Vladau C, Franek JA, Feng B, Urquhart BL, Zhong R, Freeman DJ, Garcia B, Min WP (2006) Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference. J Immunol 177(8):5639\u20135646","journal-title":"J Immunol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1744-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1744-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1744-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T07:00:36Z","timestamp":1565593236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1744-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1744"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1744-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]}}}